Ballistic Ventures led a $15m Series A round in BreachRx.

Ballistic Ventures, a venture capital firm dedicated exclusively to early-stage funding and incubation for entrepreneurs and innovations in cybersecurity, led a $15m Series A round in BreachRx, a provider of the first intelligent incident response platform designed for the entire enterprise, with participation from SYN Ventures, Overline and Silver Buckshot Ventures. "BreachRx is the first incident response platform built for the messy, high-stakes reality of cyber incidents today. It delivers clarity, cross-functional coordination, privileged communication channels and audit trails. With dynamic playbooks and streamlined tasking, BreachRx enables teams to focus on the real threat — advancing adversaries — instead of scrambling over internal liability and confusion. It’s a privilege to work with the BreachRx team," Nicole Perlroth, Ballistic Ventures Founding Partner.